-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the "Regulations for the Classification of Prescription Drugs and Over-the-Counter Drugs (Trial)" (formerly Order No.
Before April 25, 2021, the holder of the drug marketing authorization shall, in accordance with the "Administrative Measures for Drug Registration" and other relevant regulations, report the revised drug insert to the provincial drug supervision and administration department for the record, and notify the relevant medical institutions and medical institutions of the revised contents of the insert in a timely manner.
The contents of the non-prescription drug inserts other than those specified in the template inserts shall be implemented in accordance with the original approval documents
Hereby announce
Attachment: 1.
2.
State Food and Drug Administration
January 26, 2021
Announcement No.
Annex 2 of the Announcement No.